Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)
1 clinical trials · Condition
◉ Watch Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for INC424, Ruxolitinib (NCT04745637) | Novartis Pharmaceuticals |
Track Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD) automatically
Every clearance here is in the API, with alerts when new ones post.